Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Barnett

Showing results (361-370 of 409) with videos related to

Pageof 41
Sort By:
Plos One|July 22, 2016
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern AfricaCarlo Zambonelli, Antu K Dey, Susan Hilt, et al.
AIDS Research and Human Retroviruses|July 16, 2008
A therapeutic SIV DNA vaccine elicits T-cell immune responses, but no sustained control of viremia in SIVmac239-infected rhesus macaquesJan zur Megede, Brigitte Sanders-Beer, Peter Silvera, et al.
Plos One|April 18, 2012
Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvantsRachel P J Lai, Michael S Seaman, Paul Tonks, et al.
Journal of Virology|June 19, 2015
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman PrimatesMegan C Wise, Natalie A Hutnick, Justin Pollara, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Journal of Virology|July 30, 2005
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodiesBo Peng, Liqun Rejean Wang, Victor Raúl Gómez-Román, et al.
Molecular Immunology|February 3, 2009
The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cellsKyung W Song, Francisco X Talamas, Rebecca T Suttmann, et al.
Immunology|October 20, 2007
Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene deliveryAmanda Goodsell, Fengmin Zhou, Soumi Gupta, et al.
Journal of Virology|April 16, 2010
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvantSusan W Barnett, Brian Burke, Yide Sun, et al.
Journal of Virology|May 18, 2001
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable regionS W Barnett, S Lu, I Srivastava, et al.
Pageof 41

Showing results (361-370 of 409) with videos related to

Sort By:
Pageof 41
Plos One|July 22, 2016
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern AfricaCarlo Zambonelli, Antu K Dey, Susan Hilt, et al.
AIDS Research and Human Retroviruses|July 16, 2008
A therapeutic SIV DNA vaccine elicits T-cell immune responses, but no sustained control of viremia in SIVmac239-infected rhesus macaquesJan zur Megede, Brigitte Sanders-Beer, Peter Silvera, et al.
Plos One|April 18, 2012
Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvantsRachel P J Lai, Michael S Seaman, Paul Tonks, et al.
Journal of Virology|June 19, 2015
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman PrimatesMegan C Wise, Natalie A Hutnick, Justin Pollara, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Journal of Virology|July 30, 2005
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodiesBo Peng, Liqun Rejean Wang, Victor Raúl Gómez-Román, et al.
Molecular Immunology|February 3, 2009
The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cellsKyung W Song, Francisco X Talamas, Rebecca T Suttmann, et al.
Immunology|October 20, 2007
Beta7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene deliveryAmanda Goodsell, Fengmin Zhou, Soumi Gupta, et al.
Journal of Virology|April 16, 2010
Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvantSusan W Barnett, Brian Burke, Yide Sun, et al.
Journal of Virology|May 18, 2001
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable regionS W Barnett, S Lu, I Srivastava, et al.
Pageof 41